Idexx Laboratories (IDXX) Equity Average (2010 - 2026)

Idexx Laboratories' Equity Average history runs 17 years deep, the most recent figure standing at $1.6 billion for Q1 2026.

• In Q1 2026, Equity Average rose 3.88% year-over-year to $1.6 billion; the TTM figure through Mar 2026 stood at $1.6 billion (up 3.88% YoY), while the FY2025 annual figure was $1.6 billion, up 3.92% from the prior year.
• Equity Average was $1.6 billion for Q1 2026 at Idexx Laboratories, roughly flat from $1.6 billion in the prior quarter.
• In the past five years, Equity Average ranged from a high of $1.6 billion in Q4 2024 to a low of $466.5 million in Q3 2022.
• Historically, Equity Average has averaged $1.2 billion across 5 years, with a median of $1.5 billion in 2025.
• The sharpest annual moves came in 2022 and 2023: Equity Average sank 37.95% in 2022, then soared 156.46% in 2023.
• A 5-year view of Equity Average shows it stood at $542.4 million in 2022, then jumped by 156.46% to $1.4 billion in 2023, then gained by 15.51% to $1.6 billion in 2024, then fell by 1.46% to $1.6 billion in 2025, then fell by 0.16% to $1.6 billion in 2026.
• The last three Equity Average figures came in at $1.6 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.5 billion (Q3 2025), per Business Quant data.